CYTOKINETICS INC — Director's Dealing 2023

Dec 27, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2023-12-27

Reporting Person: WIERENGA WENDALL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-27	Common Stock	M	5000	$4.44	Acquired	23653	Direct
2023-12-27	Common Stock	S	5000	$73.60	Disposed	18653	Direct
2023-12-27	Common Stock	M	5000	$4.44	Acquired	23653	Direct
2023-12-27	Common Stock	S	5000	$73.60	Disposed	18653	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-27	Non-Qualified Stock Option (Right to Buy)	$4.44	M	5000	Disposed	2024-05-21	Common Stock (5000)	Direct
2023-12-27	Non-Qualified Stock Option (Right to Buy)	$4.44	M	5000	Disposed	2024-05-21	Common Stock (5000)	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023.

F2: This option shall vest and become exercisable as to 10,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 21, 2015.